Q3 FY2026 · ended Oct 2, 2026 · Revenue $558.73M, +1.8% YoY · Filed Nov 5, 2026
Enovis Corp (ENOV) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In Q3 of fiscal 2026, the quarter ended Oct 2, 2026, it reported revenue of $558.7 million and net income of $3.1 million. Free cash flow was $35.0 million. As of Oct 2, 2026 it held $13.0 million in cash and investments and $1.3 billion in total debt.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- ENOV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lewisville, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1420800
- Former names
- Colfax CORP (until Mar 18, 2022)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Oct 2, 2026 |
Q2 FY2026 Jul 3, 2026 |
Q1 FY2026 Apr 3, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Oct 3, 2025 |
|---|---|---|---|---|---|
| Revenue | $558.7M | $582.8M | $589.2M | $575.8M | $548.9M |
| Operating income | $3.4M | $17.4M | $6.5M | -$502.2M | -$558.5M |
| Net income | $3.1M | -$1.2M | -$8.8M | -$520.6M | -$571.1M |
| Diluted EPS | $0.06 | -$0.02 | -$0.15 | -$9.10 | -$9.99 |
| Operating cash flow | $71.5M | $75.0M | $24.0M | $88.5M | $82.6M |
| Free cash flow | $35.0M | $31.1M | -$28.9M | $32.3M | $29.1M |
| Total assets | $3.7B | $3.8B | $3.8B | $3.8B | $4.4B |
| Total liabilities | $2.2B | $2.3B | $2.4B | $2.3B | $2.4B |
| Stockholders' equity | $1.5B | $1.5B | $1.5B | $1.5B | $2.0B |
| Cash and investments | $13.0M | $12.6M | $33.1M | $36.4M | $33.6M |
| Total debt | $1.3B | $1.3B | $1.4B | $1.4B | $1.4B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 1, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jul 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 19, 2026 | May 19, 2026 |
All 1005 Enovis Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.